FDA Clears Cingulate to File NDA for CTx-1301 in the Treatme

The company has announced plans to submit the NDA in the first half of 2025.

Related Keywords

United States , American , Ann Childress , Shanej Schaffer , American Professional Society , Drug Administration , Behavior Medicine Inc , Cingulate Inc , New Drug Application , Related Disorders , Annual Meeting , Permanent Product Measure ,